Atypical Glandular Cells
Atypical glandular cells are the body’s early cancer warning system. If you have had a Pap test and atypical glandular cells are found, the next step is additional testing. However, if the pathologist or doctor does not read your test correctly or there is no follow-up when atypical glandular cells are found, you may develop a preventable cervical cancer. Early detection of cervical cancer can save fertility, and more importantly, save lives. Consult with a compassionate attorney if your Pap test was read incorrectly.
What are Atypical Glandular Cells
Atypical glandular cells are simply cells that do not look normal on the Pap smear. They are often called “atypical glandular cells of undetermined significance.” Glandular cells are found in the thin tissue layer making up the cervix’s inner canal, as well as in the uterus. The changes found in these cells could indicate a precancerous condition or, in rarer circumstances, actual cancer.
According to a study published in the February 2016 edition of the BMJ—formerly the British Medical Journal—1.4 percent of women diagnosed with atypical glandular cells had cervical cancer detected within six months.
That means that while a finding of atypical glandular cells is not going to result in a cervical cancer diagnosis in the short term for most women, it is a possibility. Women who have atypical glandular cells are at greater risk for developing cervical cancer over the next 15 years post-abnormal cell discovery.
Have Questions About Atypical Glandular Cells?
Call us or request a case review by our experts.

Follow-up Testing for Atypical Glandular Cells
The follow-up testing that should occur when atypical glandular cells are found includes a colposcopy and biopsy. The former is an examination of the cervix, in which the doctor inserts a speculum into the vagina to look at the cervix, located at the top of the vagina below the uterus. This simple procedure involves placing diluted white vinegar on the cervix, which causes whitening of abnormal areas.
A colposcope, an instrument with a magnifying lens and bright light, allows the doctor to get a thorough view of the cervix. A biopsy is also performed, which involves the removal of tissue for examination under a microscope. Sometimes, a biopsy is used to remove all abnormal cervical tissue as part of the treatment plan. Either way, the sample is sent to a laboratory for testing.
Unlike some other forms of possible precancerous conditions in the cervix, atypical glandular cells are not graded for the presence of cancer, but they are considered cancer markers for women. Further tests that may follow the discovery of atypical glandular cells include ultrasounds and/or CT scans.
When a Precancerous or Cancerous Condition is Found
When a precancerous or cancerous condition is found in atypical glandular cells, the doctor may remove the affected tissue via laser surgery if it has not already been removed through cold knife conization at the time of biopsy. However, many doctors prefer to use a punch biopsy tool when removing tissue for a biopsy, as it is less invasive.
The doctor can remove more tissue when using cold knife conization. Cold knife conization requires either a general or regional anesthetic. Stitches may be placed in the cervix to control bleeding, or the doctor may cauterize the area.
Learn More About Atypical Glandular Cells
If you or a loved one was diagnosed with cervical cancer after a misread Pap smear, you may need the services of an experienced medical malpractice attorney. Call today to arrange a free initial consultation.
How Could Atypical Glandular Cells Affect Your Legal Options?
Call us or request a case review by our experts.

Professional Recognition
Recognition applies to the named attorneys and selection years. See the linked profiles for details.
NOTABLE RESULTS
Published RDCY outcomes, with broader practice results identified separately:
$31,000,000 catastrophic-injury result · $2,500,000 medical-malpractice settlement
Read more about these results
RDCY’s published results list a $31,000,000 catastrophic-injury outcome in Ft. Lauderdale. This is a broader catastrophic-injury result, not an outcome for this exact case type. Source: RDCY’s published results.
The firm’s January 25, 2023 Nicole Kruegel announcement reports a $2,500,000 medical-malpractice settlement. It is shown as a broader medical-malpractice result. Firm source.
Prior results do not guarantee a similar outcome. Each case is different and must be evaluated on its own facts.
GOOGLE REVIEWS
General feedback from individual five-star Google reviews:
“Their team is highly respected in the legal community.”
— Rachel Flores-Flood
Read Rachel Flores-Flood’s Google review
“This is a top tier law firm that truly cares about its clients.”
— Eileen Epstein
Related Practice Resources
- Warning Signs of Cervical Cancer in Florida
- Types of Treatment for Cervical Cancer in Florida
- Squamous Intraepithelial Lesion
- Squamous Cell Cancer of the Cervix
- Settling a Cervical Cancer Malpractice Case in Florida
- Liability in Florida Cervical Cancer Malpractice Cases
- Filing a Cervical Cancer Malpractice Claim in Florida
- Expert Witnesses in Florida Cervical Cancer Lawsuits
- Damages in Florida Cervical Cancer Cases
- Collecting Evidence in Florida Cervical Cancer Lawsuits
- Cervical Cancer Trial
- Cervical Cancer Litigation
- Cervical Cancer Lawsuits in Florida
- Cervical Cancer Case Process in Florida
- Appealing a Florida Cervical Cancer Case
- Pap Smear Misdiagnosis
- Errors in Treating Cervical Cancer in Florida
- Delayed Diagnosis of Cervical Cancer
- Cervical Cancer Misdiagnosis
- Cervical Cancer Medical Malpractice
Need Help With a Case Involving Atypical Glandular Cells?
Call us or request a case review by our experts.



